The Pharmafocus Interview: Jan Lundberg AstraZeneca's global head of drug discovery talks about new compounds, learning from mistakes and the real heroes behind life-saving drugs.(more)
Emerging confidence Evidence-based medicine is an evolving practice, even in the developed world, but proving value is getting tougher in emerging markets too, says Ben Shankland(more)
Getting inside the customer's head Tuesday , July 12, 2005
How can pharma's marketing research improve the targeting of messages to its healthcare professional customers? Pharmafocus surveys the landscape....(more)
Because they're worth it? Monday , July 11, 2005
Are top healthcare executives being paid too much? Dr Bianca Piachaud considers the implications of a report into pay levels of the top 40 biotech and pharma companies....(more)
One Europe for pharma marketers? Wednesday, July 06, 2005
An expanding Europe may represent a huge marketing opportunity, but Andy Newman says pharma companies adopting global strategies are doomed to failure....(more)
Orphans join European pharma family Tuesday , July 05, 2005
After 17 years Europe has finally caught up with US orphan drug legislation and the last five years have seen a proliferation of orphan drug activity, says Steve Seget....(more)
All aboard the health train Friday , July 01, 2005
Sanofi-Aventis is using a 'health train' to promote public health - Jane Feinmann investigates whether such moves can cure the pharma industry's poor reputation....(more)
The myth of the 'S-shaped' curve Friday , July 01, 2005
Gary Johnson exposes some deeply held marketing beliefs as nothing more than myths and says resisting them could save the pharma industry millions....(more)
The golden rules of PR Friday , July 01, 2005
As scrutiny of pharma's marketing expenditure and practices intensifies, PR campaigns must be above reproach while still delivering results, says Liz Shanahan....(more)
